Quantitative analysis of dynamic contrast-enhanced MRI in distinguishing different grades of prostate cancer
2018-06-25nyu
, , , , U nyu*
(1.Department of Radiology, Peking University Third Hospital, Beijing 100191, China; 2.CT/MRI Division, the Central Hospital of Handan, Handan 056001, China)
前列腺癌是男性常见恶性肿瘤,患者预后受多种因素影响,个体差异较显著[1]。前列腺癌的侵袭性是影响预后的重要因素。高级别前列腺癌病情进展迅速,需及早采取前列腺癌根治术或放疗等积极治疗措施;而低级别前列腺癌则进展缓慢甚至长期无进展,仅需进行主动监测[2]。准确预测前列腺癌级别,可为个体化治疗提供依据。不同分级肿瘤的组织生物学特性各异。对比剂在不同病理组织中的药物代谢动力学不同,而动态对比增强MRI(dynamic contrast-enhanced MRI, DCE-MRI)可定量分析肿瘤组织的微血管密度及血管通透性等,从而评价肿瘤的生理特性。本研究探讨DCE-MRI定量分析在鉴别高、低级别前列腺癌中的价值。
1 资料与方法
1.1 一般资料 回顾性分析2014年1月—2016年3月于我院接受前列腺根治术并经术后病理证实为前列腺癌的26例患者,年龄50~82岁,中位年龄72岁;前列腺特异性抗原(prostate specific antigen, PSA)3.87~451.00 μg/L,中位值为17.74 μg/L;术前均接受前列腺DCE-MRI,且无内分泌、放疗等非手术治疗史,MR检查前1个月内未接受前列腺穿刺活检。
1.2 仪器与方法 采用GE Discovery 750 3.0T MR扫描仪,8通道相控阵心脏线圈。扫描序列及参数:①矢状位、冠状位和轴位快速恢复FSE T2W,TR 4 417~6 573 ms,TE 96~106 ms,矩阵288×288,FOV 22 cm×22 cm,层厚4.0 mm,层间距0.4 mm;②常规轴位FSE序列T1W,TR 750 ms,TE 7.08 ms,矩阵320×224,FOV 32 cm×32 cm,层厚5.0 mm,层间距 0.5 mm;③DWI,TR 5 000 ms,TE 61.30 ms,矩阵128×128,FOV 30 cm×30 cm,b值为0、1 000 s/mm2,层厚4.0 mm,层间距0.4 mm;④动态增强扫描采用轴位三维容积超快速多期动态序列T1W,TR 4.30 ms,TE 1.95 ms,矩阵256×128,FOV 28 cm×28 cm,层厚3.60 mm,层间距0.72 mm。注射对比剂前先扫描蒙片,后以高压注射器经肘前静脉注射对比剂Gd-DTPA,剂量为0.2 mmol/kg体质量,流率 2 ml/s,以同样流率注射20 ml生理盐水,于注射对比剂的同时开始扫描,单期扫描时间5.5 s,共采集50期。……
猜你喜欢
杂志排行
中国医学影像技术的其它文章
- CT morphological characteristics of plantar nerves and their significances in diabetic foot
- Gynecologic imaging reporting and data system combined with three-dimensional contrast-enhanced ultrasonography for differential diagnosis of benign and malignant ovarian masses
- Gd-EOB-DTPA enhanced MRI in assessing whole liver and segmental liver function
- Consistency of different physicians in diagnosis of malignant breast lesions with breast CEUS predictive model: A multicenter study
- Stretched-exponential model of DWI in differentiating malignant and benign breast lesions
- Contrast-enhanced MRA in differential diagnosis of spinal cord vascular malformation and secondary vascular tortuosity caused by non vascular malformations on spinal cord
